Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients...

por Larsson, R., Dhar, S., Ehrsson, H., Nygren, P., Lewensohn, R.
Publicado 1998

In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).

por Larsson, R., Fridborg, H., Kristensen, J., Sundström, C., Nygren, P.
Publicado 1993

Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycopr...

por Nygren, P., Larsson, R., Gruber, A., Peterson, C., Bergh, J.
Publicado 1991

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.

por Dhar, S., Nygren, P., Csoka, K., Botling, J., Nilsson, K., Larsson, R.
Publicado 1996

A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer

por Mansoori, S., Fryknäs, M., Alvfors, C., Loskog, A., Larsson, R., Nygren, P.
Publicado 2021

Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study

por Mahteme, H, Hansson, J, Berglund, Å, Påhlman, L, Glimelius, B, Nygren, P, Graf, W
Publicado 2004

Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients.

por Jonsson, E., Fridborg, H., Csóka, K., Dhar, S., Sundström, C., Nygren, P., Larsson, R.
Publicado 1997

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index

por Kashif, M., Andersson, C., Hassan, S., Karlsson, H., Senkowski, W., Fryknäs, M., Nygren, P., Larsson, R., Gustafsson, M.G.
Publicado 2015

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

por Eriksson, A, Österroos, A, Hassan, S, Gullbo, J, Rickardson, L, Jarvius, M, Nygren, P, Fryknäs, M, Höglund, M, Larsson, R
Publicado 2015

Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.

por Fridborg, H., Jonsson, B., Nygren, P., Csoka, K., Nilsson, K., Oberg, G., Kristensen, J., Bergh, J., Tholander, B., Olsen, L.
Publicado 1994

The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL.

por Nygren, P., Csoka, K., Jonsson, B., Fridborg, H., Bergh, J., Hagberg, H., Glimelius, B., Brodin, O., Tholander, B., Kreuger, A.
Publicado 1995

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles

por Rickardson, L, Fryknäs, M, Dhar, S, Lövborg, H, Gullbo, J, Rydåker, M, Nygren, P, Gustafsson, M G, Larsson, R, Isaksson, A
Publicado 2005

Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy

por Mortensen, A. C. L., Berglund, H., Segerström, L., Walle, M., Hofström, C., Persson, H., Nygren, P.-Å., Nilvebrant, J., Frejd, F. Y., Nestor, M.
Publicado 2023

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer—results from the RAPIDO trial

por Dijkstra, E.A., Zwart, W.H., Nilsson, P.J., Putter, H., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Frödin, J.E., Nygren, P., Østergaard, L., Kersten, C., Verbiené, I., Cervantes, A., Hendriks, M.P., Capdevila, J., Edhemovic, I., van de Velde, C.J.H., Marijnen, C.A.M., van Etten, B., Hospers, G.A.P., Glimelius, B.
Publicado 2023